Exploring the effects of CBD in the real world: Spotlight on Radicle ACES, history’s largest clinical trial of CBD products
Join Radicle Science for a discussion on the preliminary findings from Radicle ACES (Advancing CBD Education & Science), history’s largest clinical trial on CBD. Radicle ACES was a four-week, IRB approved, randomized controlled trial involving nearly 3,000 participants assigned to one of 13 commercially available CBD products or a waitlist control, that tracked validated health outcomes measures across well-being, quality of life, pain, anxiety, and sleep quality.
We hope you join Dr. Jeff Chen, MD/MBA, Co-founder and CEO of Radicle Science while he chats with Rosemary Mazanet, MD/PhD, CSO of Columbia Care; and Gavin Chandler, CFA, CEO of Trokie® about the Radicle ACES study, as well as the Cannabis industry as a whole.
Preliminary agenda (this will be an approx. 40 min discussion with 15 min Q&A):
Current industry challenges
Radicle ACES: industry impact, top line findings, design
Columbia Care and Radicle ACES findings
- Trokie® and Radicle ACES findings